نتائج البحث

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

• Authors : Chongqing Bovax Biopharmaceutical Co., Ltd.

• Source: Evaluating the Immunogenicity and Safety of 9-valent Human Papillomavirus(Type6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine in

تفاصيل العنوان

Evaluation of Barriers Affecting the Design and Manufacture of the Recombinant Vaccine in Iran.

• Authors : Bahadori, MohammadKarim¹; Mohammadian, Mohammad¹; Farajzadeh, Mohsen Abbasi^1,2

Subjects: *RECOMBINANT DNA; *VACCINE development; *STATISTICAL samplingIRAN

• Source: Journal of Military Medicine. Mar/Apr2024, Vol. 26 Issue 1, p2158-2164. 7p.

تفاصيل العنوان

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

• Source: A Multicenter,Randomized,Blind and Positive-Controlled Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58)

تفاصيل العنوان

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

• Source: Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM,

تفاصيل العنوان

Subclinical infection caused by a recombinant vaccine-like strain poses high risks of lumpy skin disease virus transmission

• Authors : Irina Shumilova; Pavel Prutnikov; Ali Mazloum

Subjects: lumpy skin disease virus; recombinant vaccine-like viruses; subclinical infection

• Source: Frontiers in Veterinary Science, Vol 11 (2024)

تفاصيل العنوان

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

• Authors : Chongqing Bovax Biopharmaceutical Co., Ltd.

• Source: A Randomized, Double-Blind and Positive-Controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58)

تفاصيل العنوان

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.

• Authors : Iwata, Satoshi¹ (AUTHOR); Pollard, Andrew J.^2,3 (AUTHOR); Tada, Yukio⁴ (AUTHOR)

• Source: Scientific Reports. 4/29/2024, Vol. 14 Issue 1, p1-11. 11p.

تفاصيل العنوان

Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits.

• Authors : Bosco-Lauth, Angela M.¹ (AUTHOR) ; Schueler, Amber² (AUTHOR); Midthun, Edward¹ (AUTHOR)

Subjects: *VIRUS diseases; *VACCINATION; *RABBITSUNITED States

• Source: Viruses (1999-4915). Apr2024, Vol. 16 Issue 4, p538. 10p.

تفاصيل العنوان

Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

• Authors : Fakultas Kedokteran Universitas Indonesia; Faculty of Medicine Universitas Diponegoro; Faculty of Medicine Universitas Andalas

• Source: Immunogenicity & Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 Compared to Registered

تفاصيل العنوان

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

• Authors : Universitas Padjadjaran

• Source: Immunogenicity and Safety of IndoVac® as a Heterologous Booster Dose Against COVID-19 in Children 12-17 Years of Age

تفاصيل العنوان